3,491
Views
3
CrossRef citations to date
0
Altmetric
Review

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 183-195 | Received 05 Aug 2021, Accepted 23 Nov 2021, Published online: 23 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Richard N van Zyl-Smit, Kenneth R Chapman, Huib AM Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann & Peter D’Andrea. (2023) Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma. Journal of Asthma and Allergy 16, pages 123-134.
Read now

Articles from other publishers (2)

Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella & Girolamo Pelaia. (2023) Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 17, pages 175346662311557.
Crossref
Luigi La Via, Filippo Sanfilippo, Giuseppe Cuttone, Veronica Dezio, Monica Falcone, Serena Brancati, Claudia Crimi & Marinella Astuto. (2022) Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. European Journal of Clinical Pharmacology 78:10, pages 1613-1622.
Crossref